Health Care & Life Sciences » Biotechnology | Dynavax Technologies Corp.

Dynavax Technologies Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
189,376.00
122,652.00
196,125.00
81,415.00
191,854.00
145,536
Total Accounts Receivable
1,627.00
727.00
1,394.00
1,342.00
854.00
3,704
Inventories
-
-
-
-
312.00
19,022
Other Current Assets
1,375.00
4,058.00
2,427.00
6,842.00
5,003.00
6,102
Total Current Assets
192,378.00
127,437.00
199,946.00
89,599.00
198,023.00
174,364
Net Property, Plant & Equipment
8,706.00
7,924.00
13,804.00
17,174.00
16,619.00
17,064
Total Investments and Advances
662.00
632.00
609.00
602.00
629.00
619
Intangible Assets
2,579.00
2,277.00
2,043.00
1,971.00
2,244.00
13,861
Other Assets
297.00
20.00
231.00
334.00
1,270.00
4,976
Total Assets
204,622.00
138,290.00
216,633.00
109,680.00
218,785.00
210,884
Accounts Payable
1,901.00
1,159.00
3,433.00
3,796.00
4,539.00
Other Current Liabilities
14,291.00
19,120.00
25,352.00
16,240.00
14,054.00
Total Current Liabilities
16,192.00
20,279.00
28,785.00
20,036.00
18,593.00
Long-Term Debt
-
9,559.00
-
-
-
Other Liabilities
2,136.00
7,970.00
769.00
443.00
643.00
Total Liabilities
18,328.00
37,808.00
29,554.00
20,479.00
19,236.00
Common Equity (Total)
186,294.00
100,482.00
187,079.00
89,201.00
199,549.00
Total Shareholders' Equity
186,294.00
100,482.00
187,079.00
89,201.00
199,549.00
Total Equity
186,294.00
100,482.00
187,079.00
89,201.00
199,549.00
Liabilities & Shareholders' Equity
204,622.00
138,290.00
216,633.00
109,680.00
218,785.00

About Dynavax Technologies

View Profile
Address
2929 Seventh Street
Berkeley California 94710
United States
Employees -
Website http://www.dynavax.com
Updated 07/08/2019
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases.